Guardian Pharmacy Services Inc. (GRDN)
NYSE NYSE Primary Summary
Guardian Pharmacy Services Q2 Earnings Call Highlights
Guardian Pharmacy Services NYSE: GRDN reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it continued to offset profitability pressure from Inflation Reduction Act-related drug pricing reductions.
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Guardian Pharmacy Services Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 23 | $805.78 | $931.5 | $125.72 | 15.6% |
| NA Nizar Araji National Bank Of Canada /FI/ | 2 | $83.74 | $87.1 | $3.36 | 4.01% |
| SN Susan Norris Alpine Woods Capital Investors LLC | 8,996 | $376,662.52 | $394,294.68 | $17,632.16 | 4.68% |
| CAL CSM Advisors LLC CSM Advisors LLC | 74,005 | $1.77M | $2.84M | $1.07M | 60.62% |
 Joseph Castro Nuveen LLC | 220,791 | $5.44M | $9.16M | $3.72M | 68.4% |
Guardian Pharmacy Services Inc. (GRDN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Guardian Pharmacy Services Inc. ever had a stock split?
Guardian Pharmacy Services Inc. Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Fred Burke CEO | NYSE Exchange | 40145W101 CUSIP |
| US Country | 3,600 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Guardian Pharmacy Services, Inc. is a specialized company that focuses on providing a broad spectrum of pharmacy services specifically tailored for long-term health care facilities (LTCFs) across the United States. Founded in 2003 and headquartered in Atlanta, Georgia, Guardian Pharmacy operates with the vision of enhancing the quality of care for residents in lower acuity LTCFs, which include assisted living facilities, behavioral health facilities, and group homes. By integrating technology into their services, they seek to ensure that each resident receives personalized clinical services, along with efficient drug dispensing and administration solutions.
Products and Services
- Guardian Compass
- GuardianShield Programs for LTCFs
A cornerstone tool developed by Guardian Pharmacy Services, the Guardian Compass is designed to empower local pharmacies with robust dashboards derived from comprehensive data analytics stored in the company's data warehouse. This specialized resource assists pharmacies in planning, tracking, and optimizing their operational processes, ensuring that they can provide the highest level of service to LTCFs. Through the analytical insights offered, pharmacies are better equipped to manage their inventory, streamline their dispensing procedures, and enhance overall patient care.
Specifically tailored for Long-Term Care Facilities, the GuardianShield Programs serve as a suite of services aimed at bolstering the safety and efficacy of medication management within these settings. This includes providing comprehensive clinical support to facility staff, ensuring that medication administrations are accurate and in compliance with regulatory standards, and implementing safeguard measures to prevent medication errors. The program not only emphasizes the importance of drug safety but also focuses on customizing medication management protocols to meet the unique needs of each facility, thereby promoting better health outcomes for residents.
